ArticleFrontiers in medicine2026

A pathology-based surrogate model for chemotherapy decision-making in intermediate-risk luminal breast cancer: validation of histologic grade and Ki67 in a Chinese population.

Guanhong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.